Literature DB >> 16467321

Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines.

Sandra Romero-Steiner1, Carl E Frasch, George Carlone, Roland A Fleck, David Goldblatt, Moon H Nahm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16467321      PMCID： PMC1391943          DOI： 10.1128/CVI.13.2.165-169.2006

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


× No keyword cloud information.
  16 in total

1.  Development of a multi-specificity opsonophagocytic killing assay.

Authors:  M H Nahm; D E Briles; X Yu
Journal:  Vaccine       Date:  2000-06-01       Impact factor: 3.641

2.  Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.

Authors:  S Romero-Steiner; D Libutti; L B Pais; J Dykes; P Anderson; J C Whitin; H L Keyserling; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

Review 3.  Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides.

Authors:  Catherine M Wernette; Carl E Frasch; Dace Madore; George Carlone; David Goldblatt; Brian Plikaytis; William Benjamin; Sally A Quataert; Steve Hildreth; Daniel J Sikkema; Helena Käyhty; Ingileif Jonsdottir; Moon H Nahm
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

Review 4.  Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.

Authors:  Luis Jódar; Jay Butler; George Carlone; Ron Dagan; David Goldblatt; Helena Käyhty; Keith Klugman; Brian Plikaytis; George Siber; Robert Kohberger; Ih Chang; Thomas Cherian
Journal:  Vaccine       Date:  2003-07-04       Impact factor: 3.641

5.  High-throughput imaging of bacterial colonies grown on filter plates with application to serum bactericidal assays.

Authors:  Xu Liu; Su Wang; Lisa Sendi; Michael J Caulfield
Journal:  J Immunol Methods       Date:  2004-09       Impact factor: 2.303

6.  Fluorescent multivalent opsonophagocytic assay for measurement of functional antibodies to Streptococcus pneumoniae.

Authors:  Kathryn T Bieging; Gowrisankar Rajam; Patricia Holder; Ross Udoff; George M Carlone; Sandra Romero-Steiner
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

7.  Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable?

Authors:  M Väkeväinen; W Jansen; E Saeland; I Jonsdottir; H Snippe; A Verheul; H Käyhty
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

8.  Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies.

Authors:  Kyung Hyo Kim; Jigui Yu; Moon H Nahm
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

9.  Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae.

Authors:  Sandra Romero-Steiner; Carl Frasch; Nelydia Concepcion; David Goldblatt; Helena Käyhty; Merja Väkeväinen; Craig Laferriere; Dominique Wauters; Moon H Nahm; Mark F Schinsky; Brian D Plikaytis; George M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

10.  Multiplex opsonophagocytosis assay (MOPA): a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine.

Authors:  D Bogaert; M Sluijter; R De Groot; P W M Hermans
Journal:  Vaccine       Date:  2004-09-28       Impact factor: 3.641
View more
  86 in total

1.  Pneumococcal polysaccharide vaccine at 12 months of age produces functional immune responses.

Authors:  Paul V Licciardi; Anne Balloch; Fiona M Russell; Robert L Burton; Jisheng Lin; Moon H Nahm; Edward K Mulholland; Mimi L K Tang
Journal:  J Allergy Clin Immunol       Date:  2012-02-02       Impact factor: 10.793

2.  Pneumococcal capsular polysaccharide vaccine-mediated protection against serotype 3 Streptococcus pneumoniae in immunodeficient mice.

Authors:  Haijun Tian; Avi Groner; Marianne Boes; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

3.  Anti-Pneumococcal Capsular Polysaccharide Antibody Response and CD5 B Lymphocyte Subsets.

Authors:  Leen Moens; Bert Verbinnen; Kris Covens; Greet Wuyts; Marina Johnson; Lucy Roalfe; David Goldblatt; Isabelle Meyts; Xavier Bossuyt
Journal:  Infect Immun       Date:  2015-05-04       Impact factor: 3.441

4.  Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.

Authors:  F M Russell; J R Carapetis; R L Burton; J Lin; P V Licciardi; A Balloch; L Tikoduadua; L Waqatakirewa; Y B Cheung; M L K Tang; M H Nahm; E K Mulholland
Journal:  Vaccine       Date:  2010-10-31       Impact factor: 3.641

Review 5.  Pneumococcal vaccine and opsonic pneumococcal antibody.

Authors:  Joon Young Song; M Allen Moseley; Robert L Burton; Moon H Nahm
Journal:  J Infect Chemother       Date:  2013-05-09       Impact factor: 2.211

6.  Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo.

Authors:  Kevin Fabrizio; Catherine Manix; Allan J Guimaraes; Joshua D Nosanchuk; Liise-Anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2010-03-03

7.  Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in Mexico.

Authors:  Juan Carlos Tinoco; Christine Juergens; Guillermo M Ruiz Palacios; Jorge Vazquez-Narvaez; Hermann Leo Enkerlin-Pauwells; Vani Sundaraiyer; Sudam Pathirana; Elena Kalinina; William C Gruber; Daniel A Scott; Beate Schmoele-Thoma
Journal:  Clin Vaccine Immunol       Date:  2014-12-10

8.  Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A.

Authors:  Hyunju Lee; Moon H Nahm; Robert Burton; Kyung-Hyo Kim
Journal:  Clin Vaccine Immunol       Date:  2009-01-14

9.  Testing Anti-Pneumococcal Antibody Function Using Bacteria and Primary Neutrophils.

Authors:  Manmeet Bhalla; Shaunna R Simmons; Essi Y I Tchalla; Elsa N Bou Ghanem
Journal:  Methods Mol Biol       Date:  2021

10.  Differential effects of pneumococcal vaccines against serotypes 6A and 6C.

Authors:  In H Park; Matthew R Moore; John J Treanor; Stephen I Pelton; Tamara Pilishvili; Bernard Beall; Mark A Shelly; Barbara E Mahon; Moon H Nahm
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.